Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Neoplasms 2Breast Neoplasms 2Ovarian Neoplasms 1Lymphoma, Follicular 1Depression 1Dementia 1Colonic Neoplasms 1COVID-19 1Breast Cancer Screening 1

Interventions

Leucovorin 38Fluorouracil 36Oxaliplatin 34Bevacizumab 34Irinotecan 32Cetuximab 23Capecitabine 18Panitumumab 14IFL protocol 7Folfox protocol 6Celecoxib 6Radiotherapy 5Nivolumab 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gene Expression Profiling 5regorafenib 4pembrolizumab 4dehydroftorafur 4Ramucirumab 4Fluorodeoxyglucose F18 4Floxuridine 4aflibercept 3Surgical Procedures, Operative 3Sorafenib 3Radiosurgery 3Ipilimumab 3Gemcitabine 3Fentanyl 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Colonic Neoplasms × Decision Support Techniques × Clear all
NCT04548531 2023-02-22

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Massachusetts General Hospital

Phase NA Completed
800 enrolled 13 charts
Gastrointestinal

COVID-19, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡